169 related articles for article (PubMed ID: 36529497)
1. Evaluating the Elasticity of Metastatic Cervical Lymph Nodes in Head and Neck Squamous Cell Carcinoma Patients Using DWI-based Virtual MR Elastography.
Jung HN; Ryoo I; Suh S; Lee YH; Kim E
Magn Reson Med Sci; 2024 Jan; 23(1):49-55. PubMed ID: 36529497
[TBL] [Abstract][Full Text] [Related]
2. The Diagnostic Value of Diffusion-Weighted Imaging in Differentiating Metastatic Lymph Nodes of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Suh CH; Choi YJ; Baek JH; Lee JH
AJNR Am J Neuroradiol; 2018 Oct; 39(10):1889-1895. PubMed ID: 30213809
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-Weighted Imaging (DWI) derived from PET/MRI for lymph node assessment in patients with Head and Neck Squamous Cell Carcinoma (HNSCC).
Freihat O; Pinter T; Kedves A; Sipos D; Cselik Z; Repa I; Kovács Á
Cancer Imaging; 2020 Aug; 20(1):56. PubMed ID: 32771060
[TBL] [Abstract][Full Text] [Related]
4. T1 and T2 mapping for identifying malignant lymph nodes in head and neck squamous cell carcinoma.
Qu J; Pan B; Su T; Chen Y; Zhang T; Chen X; Zhu X; Xu Z; Wang T; Zhu J; Zhang Z; Feng F; Jin Z
Cancer Imaging; 2023 Dec; 23(1):125. PubMed ID: 38105217
[TBL] [Abstract][Full Text] [Related]
5. Validity of 3-Tesla diffusion-weighted magnetic resonance imaging for distinction of reactive and metastatic lymph nodes in head-and-neck carcinoma.
Vijayalakshmi K; Raghuram PH; Saravanan K; Krithika CL; Kannan A
J Cancer Res Ther; 2020; 16(3):587-593. PubMed ID: 32719272
[TBL] [Abstract][Full Text] [Related]
6. Is diffusion-weighted MRI useful for differentiation of small non-necrotic cervical lymph nodes in patients with head and neck malignancies?
Lim HK; Lee JH; Baek HJ; Kim N; Lee H; Park JW; Kim SY; Cho KJ; Baek JH
Korean J Radiol; 2014; 15(6):810-6. PubMed ID: 25469094
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic value of cervical lymph node metastasis in head and neck squamous carcinoma by using diffusion-weighted magnetic resonance imaging and computed tomography perfusion.
Zhong J; Lu Z; Xu L; Dong L; Qiao H; Hua R; Gong Y; Liu Z; Hao C; Liu X; Zong C; He L; Liu J
Biomed Res Int; 2014; 2014():260859. PubMed ID: 25050333
[TBL] [Abstract][Full Text] [Related]
8. Assessment of metastatic lymph nodes in head and neck squamous cell carcinomas using simultaneous
Chen J; Hagiwara M; Givi B; Schmidt B; Liu C; Chen Q; Logan J; Mikheev A; Rusinek H; Kim SG
Sci Rep; 2020 Nov; 10(1):20764. PubMed ID: 33247166
[TBL] [Abstract][Full Text] [Related]
9. Utility of diffusion MRI characteristics of cervical lymph nodes as disease classifier between patients with head and neck squamous cell carcinoma and healthy volunteers.
Papoutsaki MV; Sidhu HS; Dikaios N; Singh S; Atkinson D; Kanber B; Beale T; Morley S; Forster M; Carnell D; Mendes R; Punwani S
NMR Biomed; 2021 Nov; 34(11):e4587. PubMed ID: 34240782
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of diffusion-weighted imaging and
Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
[TBL] [Abstract][Full Text] [Related]
11. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging.
Vandecaveye V; De Keyzer F; Vander Poorten V; Dirix P; Verbeken E; Nuyts S; Hermans R
Radiology; 2009 Apr; 251(1):134-46. PubMed ID: 19251938
[TBL] [Abstract][Full Text] [Related]
12. Multi-parametric arterial spin labeling and diffusion-weighted imaging in differentiation of metastatic from reactive lymph nodes in head and neck squamous cell carcinoma.
Razek AAKA; Helmy E
Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2529-2535. PubMed ID: 33000301
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of 3T diffusion-weighted MRI for discrimination of reactive and metastatic cervical lymph nodes in patients with oral squamous cell carcinoma: a pilot study.
Si J; Huang S; Shi H; Liu Z; Hu Q; Wang G; Shen G; Zhang D
Dentomaxillofac Radiol; 2014; 43(3):20130202. PubMed ID: 24408820
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of diffusion-weighted imaging in predicting cervical lymph node metastasis in head and neck malignancies.
Zhou Y; Yu T; Rui X; Jin T; Huang Z; Huang Z
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Jan; 131(1):122-129.e2. PubMed ID: 32807714
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Value of Diffusion Weighted Magnetic Resonance Imaging in Evaluation of Metastatic Neck Lymph Nodes in Head and Neck Cancer: A Sample of Iranian Patient.
Alamolhoda F; Faeghi F; Bakhshandeh M; Ahmadi A; Sanei Taheri M; Aabbasi S
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1789-1795. PubMed ID: 31244301
[TBL] [Abstract][Full Text] [Related]
16. The role of 3 Tesla diffusion-weighted imaging in the differential diagnosis of benign versus malignant cervical lymph nodes in patients with head and neck squamous cell carcinoma.
Barchetti F; Pranno N; Giraldi G; Sartori A; Gigli S; Barchetti G; Lo Mele L; Marsella LT
Biomed Res Int; 2014; 2014():532095. PubMed ID: 25003115
[TBL] [Abstract][Full Text] [Related]
17. Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes.
Holzapfel K; Duetsch S; Fauser C; Eiber M; Rummeny EJ; Gaa J
Eur J Radiol; 2009 Dec; 72(3):381-7. PubMed ID: 18995981
[TBL] [Abstract][Full Text] [Related]
18. Apparent diffusion coefficient for discriminating metastatic lymph nodes in patients with squamous cell carcinoma of the head and neck.
Pekçevik Y; Çukurova İ; Arslan İB
Diagn Interv Radiol; 2015; 21(5):397-402. PubMed ID: 26200481
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted imaging in oral squamous cell carcinoma using 3 Tesla MRI: is there a chance for preoperative discrimination between benign and malignant lymph nodes in daily clinical routine?
Wendl CM; Müller S; Eiglsperger J; Fellner C; Jung EM; Meier JK
Acta Radiol; 2016 Aug; 57(8):939-46. PubMed ID: 26454065
[TBL] [Abstract][Full Text] [Related]
20. The Utility of Ultrasonography in the Diagnosis of Cervical Lymph Nodes after Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma.
Terada H; Shimode Y; Furukawa M; Sato Y; Hanai N
Medicina (Kaunas); 2021 Apr; 57(5):. PubMed ID: 33922457
[No Abstract] [Full Text] [Related]
[Next] [New Search]
